Preventing cervical cancer: Pediatrician's role

Indian Pediatrics

Volumn 46, Issue 3, 2009, Pages 201-203

  Choudhury, Panna ^a  

^a LOK NAYAK HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE; VIRUS DNA;

CANCER IMMUNIZATION; CANCER SCREENING; CONFERENCE PAPER; DISEASE COURSE; DRUG EFFICACY; DRUG SAFETY; FATIGUE; FEVER; HEADACHE; HEALTH CARE SYSTEM; HEALTH PROGRAM; HUMAN; IMMUNITY; INJECTION PAIN; INJECTION SITE DISCOLORATION; MYALGIA; PAPANICOLAOU TEST; PEDIATRICIAN; PRACTICE GUIDELINE; UNSPECIFIED SIDE EFFECT; UTERINE CERVIX CANCER; WART VIRUS;

ADOLESCENT; ADULT; CHILD; FEMALE; HUMANS; MASS SCREENING; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 62949229279     PISSN: 00196061     EISSN: 00196061     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (16)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108.
2. Parkin DM, Bray F. Chapter 2: The burden ofHPV-related cancers. Vaccine 2006; 24 (suppl 3): S11-25.
3. Yang BH, Bray FI, Arkin DM, Sellors JW, Zhang ZF. Cervical cancer as a priority for prevention in different world regions: an evaluation using years of life lost. Int J Cancer 2004; 109: 418-424.
4. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. Human papilloma virus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189: 12-19.
5. Rambout L, Hopkins L, Hutton B, Fergusson D Prophylactic vaccination against human papilloma virus infection and disease in women: a systematic review of randomized controlled trials. CMAJ 2007; 177: 469-479.
6. Munoz N, Bosch FX, de Saniose, Herrero R, Castellsague X, Shah KV, et al. Epidemiological classification of human papilloma virus types associated with cervical cancer. N Engl J Med 2003; 348: 518-527.
7. Bhatla N, Lal N, Bao YP, Nq T, Qiao YL. A metaanalysis of human papillomavirus type-distribution in women from South Asia: implications for vaccination. Vaccine 2008; 26: 2811-2817.
8. Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S. Human Papilloma Virus and cervical cancer. Lancet 2007; 370: 890-907.
9. Bhatla N, Gulati A, Mathur SR, Rani S, Anand K, Muwonge R, et al. Evaluation of cervical screening in rural North India. Int J Gynecol Obstet 2009: Feb 4 (Epub ahead of print).
10. Diaz M, Kim JJ, Albero G, de Sanjosé S, Clifford G, Bosch FX, et al. Health and economic impact of HPV 16 and 18 vaccination and cervical cancer screening in India. Br J Cancer 2008; 99: 230-238.
11. Pollack AE, Balkin M, Edouard L, Cutts F, Broutet N; WHO/UNFPA Working Group on Sexual and Reproductive Health and HPV Vaccines. Ensuring access to HPV vaccines through integrated services: A reproductive health perspective. Bull World Health Organ 2007; 8: 57-63.
12. Barr E, Tamms G. Quadrivalent human papillomavirus vaccine. Clin Infect Dis 2007; 45: 609-617.
13. Paavonen J, Jenkins D, Bosch FX, Naud P, Salmerón J, Wheeler CM, et al. Efficacy of a prophylactic adjuvanted bivalent L1 virus-like particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomized controlled trial. Lancet 2007; 369: 2161-2170.
14. Olsson SE, Villa LL, Costa RL , Petta CA, Andrade RP, Malm C, et al. Induction of immune memory following administration of a prophylactic quadrivalent human papillomavirus (HPV) types6/11/16/18 L1 virus-like particle (VLP) vaccine Vaccine 2007; 25: 4931-4939.
15. Indian Academy of Pediatrics Committee on Immunization (IAPCOI). Consensus recommendations on Immunization, 2008. Indian Pediatr 2008: 45: 636-648.
16. Blatter MM, Monk BJ. The pediatrician's role in preventing cervical cancer. Clin Pediatr 2008; 47: 627-638.